Found: 18
Select item for more details and to access through your institution.
Clinically‐suspected cast nephropathy: A retrospective, national, real‐world study.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 11, p. 1352, doi. 10.1002/ajh.25959
- By:
- Publication type:
- Article
Causes of early death in multiple myeloma patients who are ineligible for high-dose therapy with hematopoietic stem cell support: A study based on the nationwide Danish Myeloma Database.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 4, p. E73, doi. 10.1002/ajh.23932
- By:
- Publication type:
- Article
Human P2X7 Receptor Causes Cycle Arrest in RPMI-8226 Myeloma Cells to Alter the Interaction with Osteoblasts and Osteoclasts.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 11, p. 2341, doi. 10.3390/cells9112341
- By:
- Publication type:
- Article
Immunoparesis in newly diagnosed Multiple Myeloma patients: Effects on overall survival and progression free survival in the Danish population.
- Published in:
- PLoS ONE, 2017, v. 12, n. 12, p. 1, doi. 10.1371/journal.pone.0188988
- By:
- Publication type:
- Article
Monoclonal Antibodies for Diagnosis and Potential Therapy of Small Cell Lung Cancer-The Ganglioside Antigen Fucosyl-Gm<sub>1</sub>.
- Published in:
- Acta Oncologica, 1993, v. 32, n. 7/8, p. 845, doi. 10.3109/02841869309096145
- By:
- Publication type:
- Article
A functional polymorphism in the promoter region of the IL1 B gene is associated with risk of multiple myeloma.
- Published in:
- British Journal of Haematology, 2012, v. 158, n. 4, p. 515, doi. 10.1111/j.1365-2141.2012.09141.x
- By:
- Publication type:
- Article
The polymorphism IL-1β T-31C is associated with a longer overall survival in patients with multiple myeloma undergoing auto-SCT.
- Published in:
- Bone Marrow Transplantation, 2009, v. 43, n. 7, p. 539, doi. 10.1038/bmt.2008.351
- By:
- Publication type:
- Article
Smoldering multiple myeloma risk factors for progression: a Danish population-based cohort study.
- Published in:
- European Journal of Haematology, 2016, v. 97, n. 3, p. 303, doi. 10.1111/ejh.12728
- By:
- Publication type:
- Article
Polymorphisms in the heparanase gene in multiple myeloma association with bone morbidity and survival.
- Published in:
- European Journal of Haematology, 2015, v. 94, n. 1, p. 60, doi. 10.1111/ejh.12401
- By:
- Publication type:
- Article
Genetic variants in the P2 RX7 gene are associated with risk of multiple myeloma.
- Published in:
- European Journal of Haematology, 2014, v. 93, n. 2, p. 172, doi. 10.1111/ejh.12353
- By:
- Publication type:
- Article
Improved survival of multiple myeloma patients with late relapse after high-dose treatment and stem cell support, a population-based study of 348 patients in Denmark in 1994–2004.
- Published in:
- European Journal of Haematology, 2010, v. 85, n. 3, p. 209, doi. 10.1111/j.1600-0609.2010.01465.x
- By:
- Publication type:
- Article
Increased Level of both CD4+FOXP3+ Regulatory T Cells and CD14+HLA-DR/low Myeloid-Derived Suppressor Cells and Decreased Level of Dendritic Cells in Patients with Multiple Myeloma M. K. Brimnes et al. Immune Impairment in Patients with Multiple Myeloma.
- Published in:
- Scandinavian Journal of Immunology, 2010, v. 72, n. 6, p. 540, doi. 10.1111/j.1365-3083.2010.02463.x
- By:
- Publication type:
- Article
A common genetic variant in 19q13·3 is associated with outcome of multiple myeloma patients treated with Total Therapy 2 and 3.
- Published in:
- British Journal of Haematology, 2016, v. 174, n. 6, p. 991, doi. 10.1111/bjh.13830
- By:
- Publication type:
- Article
No influence of the polymorphisms CYP2C19 and CYP2D6 on the efficacy of cyclophosphamide, thalidomide, and bortezomib in patients with Multiple Myeloma.
- Published in:
- BMC Cancer, 2010, v. 10, p. 404, doi. 10.1186/1471-2407-10-404
- By:
- Publication type:
- Article
Gene expression risk signatures maintain prognostic power in multiple myeloma despite microarray probe set translation.
- Published in:
- International Journal of Laboratory Hematology, 2016, v. 38, n. 3, p. 298, doi. 10.1111/ijlh.12486
- By:
- Publication type:
- Article
Single nucleotide polymorphisms in the promoter region of the IL1B gene influence outcome in multiple myeloma patients treated with high-dose chemotherapy independently of relapse treatment with thalidomide and bortezomib.
- Published in:
- Annals of Hematology, 2011, v. 90, n. 10, p. 1173, doi. 10.1007/s00277-011-1194-3
- By:
- Publication type:
- Article
The importance of a sub-region on chromosome 19q13.3 for prognosis of multiple myeloma patients after high-dose treatment and stem cell support: a linkage disequilibrium mapping in RAI and CD3EAP.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Vascular endothelial growth factor ( VEGF) gene polymorphisms may influence the efficacy of thalidomide in multiple myeloma.
- Published in:
- International Journal of Cancer, 2012, v. 131, n. 5, p. E636, doi. 10.1002/ijc.27387
- By:
- Publication type:
- Article